
R&D expenses of Moderna by type 2019
In 2019, Moderna spent some 33.3 million U.S. dollars on localized regenerative therapeutics as part of its research and development expenses. The statistic illustrates the research and development expenses of Moderna Inc. from 2017 to 2019, by type. Moderna recently became widely known for being one of two companies worldwide which started clinical trials for a vaccine to fight the coronavirus disease 2019 (COVID-19).